APA

Mathiesen C. B. K., Carlsson M. C., Brand S., Möller S. R., Idorn M., Thor Straten P., Pedersen A. E., Dabelsteen S., Halim A., Würtzen P. A., Brimnes J., Ipsen H., Petersen B. L. & Wandall H. H. (20190913). Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity. : The Journal of allergy and clinical immunology.

Chicago

Mathiesen Caroline B K, Carlsson Michael C, Brand Stephanie, Möller Svenning Rune, Idorn Manja, Thor Straten Per, Pedersen Anders E, Dabelsteen Sally, Halim Adnan, Würtzen Peter Adler, Brimnes Jens, Ipsen Henrik, Petersen Bent L and Wandall Hans H. 20190913. Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity. : The Journal of allergy and clinical immunology.

Harvard

Mathiesen C. B. K., Carlsson M. C., Brand S., Möller S. R., Idorn M., Thor Straten P., Pedersen A. E., Dabelsteen S., Halim A., Würtzen P. A., Brimnes J., Ipsen H., Petersen B. L. and Wandall H. H. (20190913). Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity. : The Journal of allergy and clinical immunology.

MLA

Mathiesen Caroline B K, Carlsson Michael C, Brand Stephanie, Möller Svenning Rune, Idorn Manja, Thor Straten Per, Pedersen Anders E, Dabelsteen Sally, Halim Adnan, Würtzen Peter Adler, Brimnes Jens, Ipsen Henrik, Petersen Bent L and Wandall Hans H. Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity. : The Journal of allergy and clinical immunology. 20190913.